Pictet-Biotech I dy GBP (FUND:B554RF5) - Fund price


Fund Report

Pictet-Biotech I dy GBP

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Size
Share Class Size (mil)7.73 GBP
(27/03/2020)
Fund Size (mil)1,166.35 USD
(27/03/2020)
Mkt Cap % 29/02/2020
FundCat
Giant6.536.91
Large34.0526.23
Medium30.2236.71
Small27.8128.76
Micro1.391.39
Valuations and Growth Rates 29/02/2020
FundCategory
Price / Earnings16.9221.75
Price/Book4.244.55
Price/Sales4.446.58
Price/Cash Flow12.1414.60
Dividend-Yield Factor0.540.41
Long-Term Projected Earnings Growth9.3110.63
Historical Earnings Growth17.4429.56
Sales Growth15.5611.78
Cash-Flow Growth16.6212.37
Book-Value Growth15.059.63

Asset Allocation % 29/02/2020

Asset Allocation
LongShortNetCat
Stocks97.120.0097.1295.98
Bonds0.000.000.000.00
Cash2.450.122.330.08
Other0.550.000.553.94
World Regions % 29/02/2020
FundCategory
Greater Europe3.038.60
United Kingdom0.962.01
Eurozone1.053.88
Europe - ex Euro1.022.71
Europe - Emerging0.000.00
Africa0.000.00
Middle East0.000.00
Americas95.4287.51
United States92.6086.64
Canada2.820.85
Latin America0.000.01
Greater Asia1.553.89
Japan0.000.86
Australasia0.000.12
Asia - Developed0.000.29
Asia - Emerging1.552.63
Stock Sector Weightings % 29/02/2020
FundCategory
Cyclical0.000.24
Basic Materials--
Consumer Cyclical--
Financial Services-0.24
Real Estate--
Sensitive0.000.92
Communication Services--
Energy--
Industrials-0.21
Technology-0.71
Defensive100.0098.84
Consumer Defensive--
Healthcare100.0098.84
Utilities--

Top 10 Holdings29/02/2020

Assets in Top 10 Holdings %47.47
Total Number of Equity Holdings54
Total Number of Bond Holdings0
NameSectorCountry%
IncreaseDecreaseNew since last portfolio
DecreaseVertex Pharmaceuticals Inc HealthcareUnited States6.96
DecreaseGilead Sciences Inc HealthcareUnited States6.67
DecreaseRegeneron Pharmaceuticals Inc HealthcareUnited States6.57
DecreaseBiogen Inc HealthcareUnited States6.37
DecreaseAmgen Inc HealthcareUnited States6.34
IncreaseSeattle Genetics Inc HealthcareUnited States4.45
DecreaseIncyte Corp HealthcareUnited States3.89
DecreaseBiomarin Pharmaceutical Inc HealthcareUnited States3.41
DecreaseNeurocrine Biosciences Inc HealthcareUnited States2.81
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.